Publications

Publications

Filter Results : (21) Arrow Down

Show Results For

Tadikonda, Satish K. Remove Tadikonda, Satish K. →

Page 1 of 21 Results →
  • October 2023
  • Case

Veeva Systems: The Next Frontier
By: Satish Tadikonda and William Marks
Related
  • October 2023
  • Case

TetraScience: Unlocking the Power of Scientific Data
By: Satish Tadikonda and William Marks
Related
  • October 2023
  • Case

Thermo Fisher Scientific: Foray Into Contract Research
By: Satish Tadikonda, William Marks and Kevin Emancipator
Related
  • October 2023
  • Case

Alnylam (A): A Loud Silence
By: Satish Tadikonda, William Marks and Shardule Shah
Related
  • October 2023
  • Case

Alnylam (B): A Loud Silence
By: Satish Tadikonda, William Marks and Shardule Shah
Related
  • October 2023
  • Case

Catalent: Catalyzing the Next Era of Growth
By: Satish Tadikonda, William Marks and Kevin Emancipator
Related
  • October 2023
  • Case

Revvity: A Symbol of Change
By: Satish Tadikonda and William Marks
Related
  • September 2023
  • Case

THREAD Research: Decentralized Clinical Trials and Beyond
By: Satish Tadikonda, Amanda McEwen and William Marks
Related
  • September 2023
  • Case

Atomwise: Strategic Opportunities in AI for Pharma
By: Satish Tadikonda
Related
  • August 2023
  • Case

Creyon Bio: A VC's Investment Thesis
By: Satish Tadikonda
Related
  • August 2023
  • Case

Constellation Pharmaceuticals: Corporate Development at a Novel Therapeutic Company
By: Satish Tadikonda and Brad Prosek
Related
  • August 2023 (Revised September 2023)
  • Case

Dicerna Pharmaceuticals: Decision Making in Clinical Trial Design and Operations
By: Satish Tadikonda and Amanda McEwen
Related
  • August 2023
  • Background Note

A Note on the Differences Between Therapeutics, Medical Devices, and Diagnostics
By: Satish Tadikonda, Ananya Zutshi, Hunter Goble and William Marks
Related
  • August 2023
  • Case

Augmenix: Space to Think Differently
By: Satish Tadikonda and Sidhant Jena
Related
  • August 2023
  • Teaching Note

Moderna: Everything, Everywhere, All at Once
By: Satish Tadikonda, Shikhar Ghosh and William Marks
Related
  • August 2023
  • Case

Morphic Therapeutic: Making the Initial Pipeline Decisions
By: Satish Tadikonda and Ananya Zutshi
Related
  • August 2023
  • Case

Sky Therapeutics: Innovating in Digital Therapeutics
By: Satish Tadikonda and Olivia Reszczynski
Shad Faraz and Alex Youssef were intrigued by the opportunities in the relatively new area of Digital Therapeutics. Despite initial successes, early entrants had struggled with reimbursement and revenue-predictability challenges. However, venture investors still...  View Details
Related
  • July 2023
  • Case

HealthVerity: Real World Data and Evidence
By: Satish Tadikonda
Andrew Kress (CEO and founder) and his team had built a promising marketplace business at HealthVerity serving its core market in healthcare, with a focus on pharmaceutical R&D and services. Thus far, HealthVerity’s products had been unique to the pharma and pharma...  View Details
Related
  • July 2023 (Revised July 2023)
  • Case

Miracle Therapeutics (A): Negotiating an IP License
By: Satish Tadikonda, Michael Singer, William Marks and Wendi Yajnik
Related
  • July 2023
  • Case

Moderna: Everything, Everywhere, All at Once
By: Satish Tadikonda, Shikhar Ghosh and William Marks
Related